Perceptions of risk and safety within injection settings: Injection drug users' reasons for attending a supervised injecting facility in Vancouver, Canada

Health, Risk and Society

Volumn 14, Issue 4, 2012, Pages 307-324

  Small, Will ^a,b   Moore, David ^c   Shoveller, Jean ^b   Wood, Evan ^a,b   Kerr, Thomas ^a,b  

^a BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c CURTIN UNIVERSITY   (Australia)

Author keywords

injection drug use; risk; risk perceptions; supervised injection facilities

Indexed keywords

COCAINE; DIAMORPHINE; METHAMPHETAMINE; MORPHINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BLOODSTREAM INFECTION; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG USE; EDUCATIONAL STATUS; FEMALE; HEALTH BEHAVIOR; HEALTH CARE FACILITY; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HEALTH HAZARD; HEPATITIS C; HOMELESSNESS; HUMAN; HYGIENE; INJECTION; INTERVIEW; INTRAVENOUS DRUG ABUSE; MALE; PATIENT MONITORING; PATIENT SAFETY; PUBLIC HEALTH SERVICE; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; RISK REDUCTION; VIOLENCE; VIRUS TRANSMISSION;

EID: 84862104041     PISSN: 13698575     EISSN: 14698331     Source Type: Journal    
DOI: 10.1080/13698575.2012.680950     Document Type: Article

References (57)

1. Bloor, M. 2008. Theorising equipment-sharing in a cohort of Scottish drug users. Health, Risk & Society, 10(6): 599-607.
2. Bourgois, P. 1998. The moral economies of homeless heroin addicts: Confronting ethnography, HIV risk, and everyday violence in San Francisco shooting encampments. Substance Use and Misuse, 33: 2323-2351.
3. Bourgois, P., Prince, B. and Moss, A. 2004. The everyday violence of hepatitis C among young women who inject drugs in San Francisco. Human Organization, 63(3): 253-264.
4. Broadhead, R.S., Kerr, T.H., Grund, J-P., and Altice, F.L. 2002. Safer injection facilities in North America: Their place in public policy and health initiatives. Journal of Drug Issues, 32 (1), 329-355
5. Burris, S. 2004. Addressing the "risk environment" for injection drug users: The mysterious case of the missing cop. Milbank Quarterly, 82: 125-156.
6. Carrier, N., Laplante, J. and Bruneau, J. 2005. Exploring the contingent reality of biomedicine: Injecting drug users, hepatitis C virus and risk. Health, Risk & Society, 7(2): 123-140.
7. Connors, M. M. 1992. Risk perception, risk taking and risk management among intravenous drug users: Implications for AIDS prevention. Social Science & Medicine, 34: 591-601.
8. DeBeck, K. 2008a. Public injecting among a cohort of injecting drug users in Vancouver, Canada. Journal of Epidemiology and Community Health, 63: 81-86.
9. DeBeck, K. 2008b. Police and public health partnerships: Evidence from the evaluation of Vancouver's supervised injection facility. Substance Abuse Treatment, Prevention and Policy, 7: 3-11.
10. Dovey, K., Fitzgerald, J. L. and Choi, Y. 2001. Safety becomes danger: Dilemmas of drug-use in public space. Health & Place, 7: 319-331.
11. Duff, C. 2003. The importance of culture and context: Rethinking risk and risk management in young drug using populations. Health, Risk & Society, 5: 285-299.
12. Fairbairn, N. 2008. Seeking refuge from violence in street-based drug scenes: Women's experiences in North America's first supervised injection facility. Social Science & Medicine, 67: 817-823.
13. Fischer, B. 2004. Drug use and urban order: Examining supervised injecting sites as 'governmentality'. International Journal of Drug Policy, 15: 357-365.
14. Fraser, S. and Moore, D. 2008. Dazzled by unity? Order and chaos in public discourse on illicit drug use. Social Science & Medicine, 66: 740-752.
15. Hedrich, D. 2004. European report on drug consumption rooms, Luxembourg: European Monitoring Centre for Drugs and Drug Addiction.
16. Kerr, T., Kimber, J. and Rhodes, T. 2007a. Drug use settings: An emerging focus for research and intervention. International Journal of Drug Policy, 18: 1-4.
17. Kerr, T. 2007b. A micro-environmental intervention to reduce the harms associated with drug-related overdose: Evidence from the evaluation of Vancouver's safer injection facility. International Journal of Drug Policy, 18(1): 37-45.
18. Kimber, J., Dolan, K. and Wodak, A. 2005. Survey of drug consumption rooms: Service delivery and perceived health and amenity impact. Drug and Alcohol Review, 24: 21-24.
19. Koester, S., Glanz, J. and Baron, A. 2005. Drug Sharing among heroin networks: Implications for HIV and Hepatitis B and C prevention. AIDS and Behavior, 9: 27-39.
20. Maher, L. and Dixon, D. 1999. Policing and public health: Law enforcement and harm minimization in a street-level drug market. British Journal of Criminology, 39(4): 488-512.
21. Marshall, B. D.L. 2008. Physical violence among a prospective cohort of injection drug users: A gender-focused approach. Drug & Alcohol Dependence, 97: 237-246.
22. McGovern, R. and McGovern, W. 2011. Voluntary risk-taking and heavy-end crack cocaine use: An edgework perspective. Health, Risk & Society, 13(5): 487-500.
23. Measham, F. 2004. "Drug and alcohol research: The case for cultural criminology". In Cultural criminology unleashed, Edited by: Ferrell, J., Hayward, K., Morrison, W. and Presdee, M. 219-230. London: The Glasshouse Press.
24. Milloy, M. J. 2008. Incarceration experiences in a cohort of active injection drug users. Drug & Alcohol Review, 27: 693-699.
25. Moore, D. 1993. "Beyond Zinberg's social setting": A processural view of illicit drug use. Drug & Alcohol Review, 12(4): 413-421.
26. Moore, D. 2004. Governing street-based injecting drug users: A critique of heroin overdose prevention in Australia. Social Science & Medicine, 59(7): 1547-1557.
27. Moore, D. 2005. "Key moments in the ethnography of drug-related harm: Reality checks for policy makers?". In Preventing harmful substance use: The evidence base for policy and practice, Edited by: Stockwell, T. R., Gruenewald, P., Toumbourou, J. and Loxley, W. 433-442. Chichester: John Wiley and Sons.
28. Moore, D. 2009. 'Workers', 'clients' and the struggle over needs: Understanding encounters between service providers and injecting drug users in an Australian city. Social Science & Medicine, 68: 1161-1168.
29. Moore, D. and Dietze, P. 2005. Enabling environments and the reduction of drug-related harm: Re-framing Australian policy and practice. Drug Alcohol Review, 24(3): 275-284.
30. MSIC Evaluation Committee. 2003. Final report on the evaluation of the Sydney Medically Supervised Injecting Centre. Sydney, MSIC Evaluation Committee
31. Nettleton, S. and Bunton, R. 1995. "Sociological critiques of health promotion". In The sociology of health promotion: Critical analyses of consumption, lifestyle and risk, Edited by: Bunton, R., Nettleton, S. and Burrows, R. 39-55. London and New York: Routledge.
32. O'Connell, J. M. 2005. Requiring help injecting independently predicts incident HIV infection among injection drug users. Journal of Acquired Immune Deficiency Syndromes, 40: 83-88.
33. O'Shaughnessy, M. Deadly public policy: The inadvertent facilitation of an HIV outbreak among IDUs in Vancouver, Canada. 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention. July2009, Capetown, South Africa.
34. Ouellet, L. 1991. Shooting galleries and HIV disease: Variations in places for injecting illicit drugs. Crime & Delinquency, 37(1): 64-85.
35. Page, B. 1990. Shooting scenarios and risk of HIV infection. American Behavioral Scientist, 33(4): 478-490.
36. Page, J. B. and Salazar, J. M. 1999. Needle use in Miami and Valencia: Observations of high and low availability. Medical Anthropology Quarterly, 13(4): 413-435.
37. Page, B., Smith, P. C. and Kane, N. 1998. Shooting galleries, their proprietors, and implications for prevention of AIDS. Drugs & Society, 5: 69-86.
38. Parkin, S. and Coomber, R. 2009. Informal 'Sorter' houses: A qualitative insight of the 'shooting gallery' phenomenon in a UK setting. Health & Place, 15(4): 981-989.
39. Rhodes, T. 1997. Risk theory in epidemic times: Sex, drugs, and the social organization of 'risk behaviour'. Sociology of Health & Illness, 19(2): 208-227.
40. Rhodes, T. 2002. The 'risk environment': A framework for understanding and reducing drug-related harm. International Journal of Drug Policy, 13: 85-94.
41. Rhodes, T. 2009. Risk environments and drug harms: A social science for harm reduction approach. International Journal of Drug Policy, 20: 193-201.
42. Rhodes, T. 2006. Public injecting and the need for 'safer environment interventions' in the reduction of drug-related harm. Addiction, 101: 1384-1393.
43. Rhodes, T., Stimson, G. V. and Quirk, A. 1996. Sex, drugs, intervention, and research: From the Individual to the Social'. Substance Use & Misuse, 31: 375-407.
44. Rhodes, T. 2005. The social structural production of HIV risk among injecting drug users. Social Science and Medicine, 61: 1026-1044.
45. Ripoll, C. A., Page, J. B. and Salazar, J. M. 2003. Drug use in sex workers on the streets of Valencia. Ethnicity in Drug Abuse, 1(4): 1-27.
46. Shannon, K. 2006. The impact of unregulated single room occupancy hotels on the health status of illicit drug users in Vancouver. International Journal of Drug Policy, 17: 107-114.
47. Shannon, K. 2008. Social and structural violence and power relations in mitigating HIV risk of drug-using women in survival sex work. Social Science & Medicine, 66(4): 911-921.
48. Singer, M. 2000. The social geography of AIDS and hepatitis risk: Qualitative approaches for assessing local differences in sterile-syringe access among injection drug users. American Journal of Public Health, 90: 1049-1056.
49. Small, W. 2006. Impacts of intensified police activity on injection drug users: Evidence from an ethnographic investigation. International Journal of Drug Policy, 17(2): 85-95.
50. Small, W. 2007. Public injection settings in Vancouver: Physical environment, social context and risk. International Journal of Drug Policy, 18: 27-36.
51. Small, W. 2011. IDU perspectives on the design and operation of North America's first medically supervised injection facility. Substance Use & Misuse, 46(5): 561-568.
52. Stoltz, J. A. 2007. Changes in injecting practices associated with the use of a medically supervised safer injection facility. Journal of Public Health (Oxf), 29(1): 35-39.
53. Tyndall, M. W. 2003. Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS, 17(6): 887-893.
54. Tyndall, M. W. 2006. Attendance, drug use patterns, and referrals made from North America's first supervised injection facility. Drug & Alcohol Dependence, 83: 193-198.
55. Weeks, M. 2001. High risk drug use sites, meaning and practice: Implications for AIDS prevention. Journal of Drug Issues, 31(1): 781-808.
56. Wood, E. and Kerr, T. 2006. What do you do when you hit rock bottom? Responding to drugs in the city of Vancouver. International Journal of Drug Policy, 17(2): 55-60.
57. Wood, E. 2006. Summary of findings from the evaluation of a pilot medically supervised safer injecting facility. Canadian Medical Association Journal, 175: 1399-1404.